Adverum Biotechnologies Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Adverum Biotechnologies, Inc. |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotechnology, annual-report
Related Tickers: ADVM
TL;DR
ADVM 2024 10-K filed. Financials and biz details out.
AI Summary
Adverum Biotechnologies, Inc. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Avalanche Biotechnologies, Inc., is focused on biological products. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides a comprehensive overview of Adverum Biotechnologies' financial health and strategic direction for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Adverum Biotechnologies faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Previous Fiscal Year (For comparative financial analysis)
- 2022 — Prior Fiscal Year (For comparative financial analysis)
Key Players & Entities
- Adverum Biotechnologies, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- Avalanche Biotechnologies, Inc. (company) — Former company name
- Redwood City, CA (location) — Business and mailing address
FAQ
What is the primary business of Adverum Biotechnologies, Inc. as described in the 10-K?
Adverum Biotechnologies, Inc. is focused on biological products, specifically in the area of biological products (no diagnostic substances) as indicated by its SIC code [2836].
When did Adverum Biotechnologies, Inc. change its name from Avalanche Biotechnologies, Inc.?
The company changed its name from Avalanche Biotechnologies, Inc. on September 21, 2010.
What is the SEC file number for this 10-K filing?
The SEC file number for this filing is 001-36579.
Where is Adverum Biotechnologies, Inc. located?
The company's business and mailing address is 100 Cardinal Way, Redwood City, CA 94063.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Adverum Biotechnologies, Inc..